January 6, 2012 - C. R. Bard recently announced it acquired drug-eluting balloon maker Lutonix Inc. for $225 million. Following successful approval of a U.S. Food and Drug Administration (FDA) pre-market approval (PMA), an additional $100 million will be paid.

January 6, 2012 - Bracco Imaging SpA has acquired Swiss Medical Care (SMC), a Swiss company headquartered in Lausanne and engaged in research, production and marketing of automated systems for the administration of contrast agents for diagnostic imaging.

January 6, 2012 – A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to this abnormal blood clotting and have turned it off using a popular class of cholesterol-lowering drugs; statins.

January 6, 2012 – Bracco Diagnostics said it plans to close out the recall process for its CardioGen-82 cardiac perfusion radiotracer with a list of actions to bring the product back to market.

January 5, 2012 – Ambucor Health Solutions (AHS) has said it is expanding its cardiovascular implantable electronic devices (CIED) monitoring program for pacemaker and implantable cardioverter defibrillator (ICD) monitoring services.

January 5, 2012 – During RSNA 2011, TeraRecon Inc. demonstrated a suite of innovative tools for its iNtuition solution to support new applications for volumetric acquisition modalities, such as computed tomography (CT), magnetic resonance (MR) and positron emission tomography (PET).

January 5, 2011 – Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the United Kingdom in two important blood-clotting disorders

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now